Prediction of the differences in tumor mutation burden between primary and metastatic lesions by radiogenomics.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer science"
DOI: 10.1111/cas.15173
Abstract: Tumor mutational burden (TMB) is gaining attention as a biomarker for responses to immune checkpoint inhibitors in cancer patients. In this study, we evaluated the status of TMB in primary and liver metastatic lesions in… read more here.
Keywords: liver metastatic; metastatic lesions; primary liver; tmb ... See more keywords